- Home
- PCVX vs AVTR Comparison
PCVX vs AVTR Comparison
Compare PCVX & AVTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | AVTR |
|---|---|---|
| Founded | 2013 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.0B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PCVX | AVTR |
|---|---|---|
| Price | $56.24 | $7.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 14 |
| Target Price | ★ $98.33 | $12.89 |
| AVG Volume (30 Days) | 1.1M | ★ 8.9M |
| Earning Date | 05-06-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $6,552,200,000.00 |
| Revenue This Year | N/A | $1.10 |
| Revenue Next Year | N/A | $1.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.09 | $7.39 |
| 52 Week High | $73.82 | $16.54 |
Technical Indicators
Market Signals| Indicator | PCVX | AVTR |
|---|---|---|
| Relative Strength Index (RSI) | 50.96 | 29.76 |
| Support Level | $42.30 | N/A |
| Resistance Level | $58.95 | $14.29 |
| Average True Range (ATR) | 2.47 | 0.33 |
| MACD | -0.62 | 0.03 |
| Stochastic Oscillator | 37.09 | 19.60 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About AVTR Avantor Inc.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.